Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

US suspends risky disease research

Nature volume 514, pages 411–412 (2014)Cite this article

Subjects

Government to cease funding gain-of-function studies that make viruses more dangerous, pending a safety assessment.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Imai, M. et al. Nature 486, 420–428 (2012).

    Article  ADS  CAS  Google Scholar 

  2. Herfst, S. et al. Science 336, 1534–1541 (2012).

    Article  ADS  CAS  Google Scholar 

  3. Watanabe, T. et al. Cell Host Microbe 15, 692–705 (2014).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Sara Reardon
    View author publications

    You can also search for this author inPubMed Google Scholar

Additional information

See Editorial page 403

Related links

Related links

Related links in Nature Research

A ripe time for gaining ground 2014-Oct-22

Safety lapses in US government labs spark debate 2014-Jul-16

Risks of flu work underrated 2014-Jul-01

Scientists call for urgent talks on mutant-flu research in Europe 2013-Dec-20

Controversial H5N1 influenza work likely to resume 2012-Dec-19

Call to censor flu studies draws fire 2012-Jan-03

Blog post: US announces rules for potential bioterror agents

Related external links

White House announcement

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reardon, S. US suspends risky disease research. Nature 514, 411–412 (2014). https://doi.org/10.1038/514411a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/514411a

Search

Advanced search

Quick links

Nature Briefing Careers

Sign up for the Nature Briefing: Careers newsletter — what matters in careers research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Careers